A $14.7 million grant from the Michael J. Fox Foundation has been awarded to Verily, Alphabet’s health data and AI subsidiary, to create a comprehensive molecular dataset for Parkinson’s disease. This initiative will combine advanced molecular profiling with a vast array of clinical, imaging, and wearable data gathered through the Personalized Parkinson’s Project (PPP). The PPP, a two-year longitudinal study conducted with Radboud University Medical Center, involved 520 Parkinson’s patients. The study amassed multimodal datasets, including biospecimens, clinical histories, imaging scans, and physiological data. Participants wore Verily’s Study Watch continuously and completed virtual motor exams, enhancing the validation of digital measures in Parkinson’s research. The molecular dataset will utilize Verily’s Immune Profiler Xseq with 30X Whole Genome Sequencing, alongside Cytokine, Metabolomic, and alpha-synuclein profiling. This high-resolution molecular analysis will be performed on existing blood and cerebrospinal fluid samples. The resulting dataset, featuring whole genome sequencing, metabolomics, alpha-synuclein biomarkers, and immunogenomic data, will be publicly accessible via Verily Workbench. This resource aims to deepen the understanding of Parkinson’s genetic, metabolic, and immune pathways, supporting new insights into disease mechanisms, improving diagnostics, and facilitating targeted therapy development.
Danny Huang, MD
@YuhaoHuangMD
·
May 4 Stem cell therapy for Parkinson’s disease has entered a new era. Two
@Nature
studies demonstrate that pluripotent stem cell–derived dopamine neurons can survive, restore function, and potentially change the treatment paradigm for this neurodegenerative disease.
Gavin Mogan
@purposeful_pd
·
May 31 The extent of our motivation can change our physiology, such that we can sometimes overcome even challenges as debilitating as Parkinson’s. In this case, a passion to treat those who suffer with none. I feel it.
This is what the Parkinson’s movement needs. We need to be moved.
Paul Stamets
@PaulStamets
·
May 26 New findings out of UCSF! Psilocybin was safely administered to people with Parkinson’s, and the results were remarkable. In addition to improved mood, participants also saw lasting gains in motor function and cognition, with no serious side effects.
This is the first time a
Global Times
@globaltimesnews
·
Jun 3 A research team from the University of California, Los Angeles has developed a pen containing magnetic ink and artificial intelligence technology that can determine the presence of Parkinson’s disease from the subtle handwriting movements. The device is expected to enable early,
Tech News
@TechnicalNewsHQ
·
Jun 4 A new era in medical diagnostics has arrived with the development of a groundbreaking AI-powered pen that can detect early signs of Parkinson’s disease simply by analyzing a person’s handwriting. Studies show that subtle changes in handwriting-such as reduced size, slower
Beatrice Zatorska
@PDbuddyapp
·
Jun 4 Unlike medications that only manage symptoms, this treatment aims to replace lost brain cells—offering potential long-term benefits with just one surgery. Powered by
@parkinsonsuk
#parkinson #parkinsonsdisease #parkinsonsawareness #parkinsonsresearch #parkinsonsnews
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
